Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

DNA repair methyltransferase (Mgmt) knockout mice are sensitive to the lethal effects of chemotherapeutic alkylating agents.

Glassner BJ, Weeda G, Allan JM, Broekhof JL, Carls NH, Donker I, Engelward BP, Hampson RJ, Hersmus R, Hickman MJ, Roth RB, Warren HB, Wu MM, Hoeijmakers JH, Samson LD.

Mutagenesis. 1999 May;14(3):339-47.

PMID:
10375003
2.

[Study on MGMT assay and tumor individual predictable chemotherapy].

Zhang YP.

Ai Zheng. 2004 Jun;23(6):724-34. Review. Chinese.

PMID:
15191682
3.

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents.

Kaina B, Christmann M, Naumann S, Roos WP.

DNA Repair (Amst). 2007 Aug 1;6(8):1079-99. Epub 2007 May 7. Review.

PMID:
17485253
4.
5.

Exploiting the role of O6-methylguanine-DNA-methyltransferase (MGMT) in cancer therapy.

Sabharwal A, Middleton MR.

Curr Opin Pharmacol. 2006 Aug;6(4):355-63. Epub 2006 Jun 13. Review.

PMID:
16777483
6.

Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers.

Srivenugopal KS, Rawat A, Niture SK, Paranjpe A, Velu C, Venugopal SN, Madala HR, Basak D, Punganuru SR.

Mini Rev Med Chem. 2016;16(6):455-64. Review.

PMID:
26202203
7.

Targeting O⁶-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy.

Kaina B, Margison GP, Christmann M.

Cell Mol Life Sci. 2010 Nov;67(21):3663-81. doi: 10.1007/s00018-010-0491-7. Epub 2010 Aug 18. Review.

PMID:
20717836
8.

O6-benzylguanine-resistant mutant MGMT genes improve hematopoietic cell tolerance to alkylating agents.

Davis BM, Koç ON, Reese JS, Gerson SL.

Prog Exp Tumor Res. 1999;36:65-81. Review. No abstract available.

PMID:
10386065
9.

MGMT: a personal perspective.

Mitra S.

DNA Repair (Amst). 2007 Aug 1;6(8):1064-70. Epub 2007 May 7. Review.

Supplemental Content

Support Center